Memantine

New Drug Approvals

Memantine

1-amino-3,5-dimethyl adamantane

Memantina, Memantinum, Ebixa, 3,5-dimethyladamantan-1-amine, 1-Amino-3,5-dimethyladamantane, Memantin, CAS 19982-08-2, Memantinum [INN-Latin]
Molecular Formula: C12H21N   Molecular Weight: 179.30184
HCL SALT      41100-52-1

REVIEW BY ARK…..http://learnabout.arkpatentintelligence.com/drug-in-focus-memantine…… GREAT REVIEW BY


Please visit www.arkpatentintelligence.com to find out more about Pipeline Patent Intelligence and how it can assist your generic drug development
Visit THEIR  product page OR
Request a call to be contacted by an Ark Patent Intelligence staff member

Memantine is an orally active NMDA (N-methyl-D-aspartate) receptor antagonist which works by blocking the NMDA receptors in the brain. It blocks the excessive activity of glutamate, but still allows the normal activation of these receptors that occurs when the brain forms a memory. Therefore it improves the brain functioning in Alzheimer’s disease, and may also block the glutamate activity that could cause further damage to the brain cells.

Memantine hydrochloride is commercially available in the market in products…

View original post 7,409 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s